4:40 PM ET
Earnings Call
▶ Call
ResMed Earnings Call: Key Takeaways
ResMed delivered strong FY2026 results with 10% revenue growth and introduced FY2027 guidance, balancing core sleep growth against a $75 million headwind from the Astral field safety action.
- Call
- Oct 29, 2026, 4:30 PM ET